One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-128683
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 1 |
Affiliation: University Cancer Center Hamburg, Universität Hamburg, University Medical Center Hamburg-Eppendorf, University of Iowa, BerGenBio (Norway), University Hospital Ulm, University Hospital Frankfurt, Goethe University Frankfurt, Hannover Medical School, Ospedale Vito Fazzi, University of Parma, Ospedale di Parma, University of Genoa, Ospedale Policlinico San Martino, Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo, Haukeland University Hospital, The University of Texas MD Anderson Cancer Center, University of BergenDurable Responses Observed in Elderly AML Patients Unfit for Intensive Chemotherapy with First-in Class Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with LDAC: Phase II Open-Label Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
